Learn more
FOCUS AREAS African Vaccine Manufacturing Accelerator (AVMA) Zero-Dose Child Gavi Secretariat and leadership Progress report Partners Our Board
CAREERS Current vacancies Internship programme RFPs and consulting
Contact us ISO certification Phishing and fraud
SUPPORTED COUNTRIESDetailed information on each Gavi-eligible countryExplore our Country Hub
FOR COUNTRIES
Apply for support
Gavi 5.0 Ceilings by country and support type
OUR RESULTS
Evaluation studies
Facts and figures
Progress reports
African Vaccine Manufacturing Accelerator (AVMA)
COVID-19
#FOROURFUTURE
Five years to save 8 million lives: everything you need to know about Gavi’s Investment Opportunity
Read article
KEY AREAS
Donor profiles
Matching Fund
Pneumococcal AMC
SPOTLIGHT ON REACHING THE UNIMMUNISED
KEY PUBLICATION
Investment Opportunity 2026–2030Download
LATEST
Progress report
News releases
Communication toolkits
Pakistan was the first county in South Asia to launch a vaccine against one of the leading cause of pneumonia among children under five.
09 October 2012
The introduction of pneumococcal vaccines is an important milestone in the fight to reduce the burden caused by pneumonia in Pakistan. The partnership between the Government of Pakistan and the GAVI Alliance – which includes UNICEF, WHO and civil society, among many other partners - to deliver this life-saving vaccine to Pakistan's children, as well as a renewed commitment to strengthening the current routine immunisation system, provides a solid foundation for a stronger, healthier nation.